Growth Metrics

Femasys (FEMY) Revenue (2020 - 2025)

Femasys posted quarterly Revenue of $409268.0 for Q2 2025, up 84.78% year-on-year from $221484.0 in Q2 2024, and up 19.93% on a QoQ basis from $341264.0 in Q1 2025.

Femasys (FEMY) has 6 years of Revenue data on file, last reported at $409268.0 in Q2 2025.

  • For the quarter ending Q2 2025, Revenue rose 84.78% year-over-year to $409268.0; the trailing twelve-month figure through Jun 2025 stood at $1.9 million (up 98.61% YoY), and the FY2025 full-year result was $2.3 million, up 40.77% from the prior year.
  • Revenue for Q2 2025 stood at $409268.0, up from $341264.0 in the prior quarter.
  • Across five years, Revenue topped out at $581576.0 in Q4 2024 and bottomed at $213111.0 in Q4 2023.
  • The 5-year median for Revenue is $311813.5 (2022), against an average of $324306.5.
  • Peak annual rise in Revenue reached 172.9% in 2024, while the deepest fall reached 30.9% in 2024.
  • A 5-year view of Revenue shows it stood at $254327.0 in 2021, then slipped by 7.9% to $234244.0 in 2022, then dropped by 9.02% to $213111.0 in 2023, then jumped by 172.9% to $581576.0 in 2024, then decreased by 29.63% to $409268.0 in 2025.
  • The last three Revenue figures came in at $409268.0 (Q2 2025), $341264.0 (Q1 2025), and $581576.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.77 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 4.71 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 1.43 Bn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 844.90 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 2.01 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 1.02 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.04 Bn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.70 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 982.87 Mn
10 Femasys 22.30 Mn 16.91 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 409,268.00
Mar 31, 2025 341,264.00
Dec 31, 2024 581,576.00
Sep 30, 2024 554,908.00
Jun 30, 2024 221,484.00
Mar 31, 2024 271,140.00
Dec 31, 2023 213,111.00
Sep 30, 2023 244,361.00
Jun 30, 2023 320,514.00
Mar 31, 2023 293,984.00
Dec 31, 2022 234,244.00
Sep 30, 2022 347,456.00
Jun 30, 2022 303,113.00
Mar 31, 2022 321,405.00
Dec 31, 2021 254,327.00
Sep 30, 2021 269,581.00
Jun 30, 2021 326,006.00
Mar 31, 2021 329,775.00
Dec 31, 2020 280,964.00
Sep 30, 2020 313,208.00
Jun 30, 2020 183,234.00